A NOVEL THERAPEUTIC APPROACH USING HISTONE DEACETYLASE INHIBITOR ROMIDEPSIN (RM) AND NATURAL KILLER CELLS IN THE TREATMENT OF HIGH RISK LEUKEMIA/LYMPHOMAS(HRLL): POTENTIAL FOR TARGETED ADOPTIVE CELLULAR IMMUNOTHERAPY
EXPERIMENTAL HEMATOLOGY（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要